Nurix (NRIX) CFO nets shares after RSU vesting tax sale
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Nurix Therapeutics Chief Financial Officer Hans van Houte reported routine equity compensation activity tied to restricted stock units (RSUs). On April 30, 2026, RSUs covering 8,608 shares of common stock vested and were converted into common shares.
To satisfy associated tax withholding obligations, 2,388 common shares were sold in an open-market transaction at a weighted average price of $16.6453 per share. The company’s equity plan required this "sell to cover" transaction, and the filing states it did not represent a discretionary trade by the executive.
Following these transactions, Hans van Houte directly holds 51,647 shares of Nurix common stock. The RSU awards vest in quarterly installments over three years, with separate grants beginning to vest on July 30, 2023, July 30, 2024, and July 30, 2025, contingent on continued service. Each RSU represents a right to receive one share of common stock upon vesting.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 2,388 shares ($39,749)
Net Sell
7 txns
Insider
van Houte Hans
Role
Chief Financial Officer
Sold
2,388 shs ($40K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 2,000 | $0.00 | -- |
| Exercise | Restricted Stock Units | 3,750 | $0.00 | -- |
| Exercise | Restricted Stock Units | 2,858 | $0.00 | -- |
| Exercise | Common Stock | 2,000 | $0.00 | -- |
| Exercise | Common Stock | 3,750 | $0.00 | -- |
| Exercise | Common Stock | 2,858 | $0.00 | -- |
| Sale | Common Stock | 2,388 | $16.6453 | $40K |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct, null);
Common Stock — 47,427 shares (Direct, null)
Footnotes (1)
- The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Represents the weighted average sale price. The lowest price at which shares were sold was $16.51 and the highest price at which shares were sold was $16.78. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2023, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting. RSUs do not expire; they either vest or are canceled prior to the vest date. The RSUs vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2024, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting. The RSUs vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2025, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting.
Key Figures
Shares sold to cover taxes: 2,388 shares
Weighted average sale price: $16.6453 per share
Shares acquired from RSU vesting: 8,608 shares
+4 more
7 metrics
Shares sold to cover taxes
2,388 shares
Open-market sale on April 30, 2026
Weighted average sale price
$16.6453 per share
Tax-related sale of common stock
Shares acquired from RSU vesting
8,608 shares
Common stock delivered upon RSU vesting
Shares held after transactions
51,647 shares
Direct common stock holdings post-April 30, 2026
First vesting date grant 1
July 30, 2023
Quarterly RSU vesting over three years
First vesting date grant 2
July 30, 2024
Quarterly RSU vesting over three years
First vesting date grant 3
July 30, 2025
Quarterly RSU vesting over three years
Key Terms
restricted stock unit ("RSU"), sell to cover, equity incentive plans, weighted average sale price, +2 more
6 terms
restricted stock unit ("RSU") financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
sell to cover financial
"funded by a "sell to cover" transaction and do not represent discretionary trades"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
equity incentive plans financial
"mandated by the Issuer's election under its equity incentive plans to require the satisfaction"
Equity incentive plans are company programs that pay employees, executives, or directors with company stock, stock options, or share units instead of or in addition to cash, aiming to align their interests with shareholders—like giving team members a stake in the house they help build. For investors this matters because such plans can motivate better company performance but also dilute existing ownership and increase reported compensation costs, so they affect future earnings, voting power, and share value.
weighted average sale price financial
"Represents the weighted average sale price. The lowest price at which shares were sold"
tax withholding obligations financial
"shares required to be sold by the Reporting Person to cover tax withholding obligations in connection"
vesting financial
"The RSUs vest as to 1/12 of the total award quarterly over three years"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What did Nurix Therapeutics (NRIX) CFO Hans van Houte report on this Form 4?
He reported RSU vesting and related tax sales. RSUs for 8,608 shares converted into common stock, and 2,388 shares were sold in a required sell-to-cover transaction to satisfy tax withholding obligations.
How do the Nurix (NRIX) CFO’s RSUs vest over time?
The filing describes three RSU awards that each vest as to 1/12 of the total grant quarterly over three years. The first quarterly vesting dates are July 30, 2023, July 30, 2024, and July 30, 2025, subject to continued service.
What does each Nurix (NRIX) restricted stock unit represent for the CFO?
Each restricted stock unit represents a contingent right to receive one share of Nurix common stock. Upon vesting, common shares are delivered to the CFO, and RSUs either fully vest or are canceled before their scheduled vest date.